Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt repayments
Ratios

Abvc Biopharma (ABVC) Long-Term Debt Issuances (2018 - 2025)

Historic Long-Term Debt Issuances for Abvc Biopharma (ABVC) over the last 10 years, with Q2 2025 value amounting to -$37329.0.

  • Abvc Biopharma's Long-Term Debt Issuances changed N/A to -$37329.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $69010.0, marking a year-over-year decrease of 8240.46%. This contributed to the annual value of $342095.0 for FY2024, which is 7661.08% down from last year.
  • Per Abvc Biopharma's latest filing, its Long-Term Debt Issuances stood at -$37329.0 for Q2 2025.
  • Abvc Biopharma's Long-Term Debt Issuances' 5-year high stood at $3.2 million during Q1 2023, with a 5-year trough of -$1.8 million in Q3 2023.
  • For the 4-year period, Abvc Biopharma's Long-Term Debt Issuances averaged around $227802.8, with its median value being $60000.0 (2024).
  • In the last 5 years, Abvc Biopharma's Long-Term Debt Issuances soared by 22989.9% in 2021 and then tumbled by 9120.26% in 2024.
  • Abvc Biopharma's Long-Term Debt Issuances (Quarter) stood at $236498.0 in 2021, then tumbled by 53.44% to $110110.0 in 2023, then crashed by 45.51% to $60000.0 in 2024, then crashed by 162.22% to -$37329.0 in 2025.
  • Its Long-Term Debt Issuances was -$37329.0 in Q2 2025, compared to $46339.0 in Q1 2025 and $60000.0 in Q4 2024.